KAYO MOTOR
834058
Zhejiang Zoenn Design
300901
Zhejiang Meorient Commerce & Exhibition Inc.
300795
Fujian Zitian Media Technology
300280
Zhejiang Prulde Electric Appliance
301353
CN Stock MarketDetailed Quotes
000908 Hunan Jingfeng Pharmaceutical
- 4.76
- -0.05-1.04%
Market Closed Dec 13 15:00 CST
4.19BMarket Cap-14.65P/E (TTM)
4.92High4.68Low248.03KlotVolume4.78Open4.81Pre Close119.81MTurnover3.14%Turnover RatioLossP/E (Static)879.77MShares6.3652wk High-26.89P/B3.76BFloat Cap0.7252wk Low5.05Limit Up788.90MShs Float28.51Historical High4.57Limit Down4.99%Amplitude0.72Historical Low--Dividend TTM4.83Avg Price123.91KlotAsk--Div YieldTTM100Lot Size120.63KlotBid
Hunan Jingfeng Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -46.79%294.7M | -46.76%202.58M | -42.87%100.58M | -21.86%656.89M | -9.48%553.83M | -5.34%380.52M | -2.95%176.06M | 3.63%840.66M | 9.30%611.82M | 28.22%402.01M |
| Operating revenue | -46.79%294.7M | -46.76%202.58M | -42.87%100.58M | -21.86%656.89M | -9.48%553.83M | -5.34%380.52M | -2.95%176.06M | 3.63%840.66M | 9.30%611.82M | 28.22%402.01M |
| Other operating revenue | ---- | 27.21%4.72M | ---- | -36.02%11.58M | ---- | -39.63%3.71M | ---- | -53.98%18.1M | ---- | -71.42%6.15M |
| Total operating cost | -40.85%335.76M | -39.93%228.13M | -38.58%103.67M | -11.00%793.08M | -7.08%567.68M | -3.27%379.79M | -1.14%168.78M | -23.98%891.13M | -15.43%610.93M | -6.99%392.62M |
| Operating cost | -12.75%118.1M | -11.30%75.07M | -14.89%33.84M | -6.93%185.52M | -0.51%135.36M | -2.98%84.63M | 10.21%39.76M | -35.19%199.33M | -28.64%136.05M | -17.96%87.23M |
| Operating tax surcharges | -63.66%3.19M | -50.73%2.55M | -44.57%1.13M | -12.29%10.81M | -2.11%8.79M | -14.58%5.18M | -5.59%2.04M | -54.94%12.33M | 1.32%8.98M | 0.64%6.06M |
| Operating expense | -63.09%101.23M | -59.45%76.78M | -56.85%36.44M | -17.74%347.05M | -9.33%274.23M | -4.43%189.34M | -0.96%84.44M | -7.34%421.88M | 4.32%302.44M | 28.42%198.11M |
| Administration expense | -27.05%78.6M | -28.48%51.15M | -25.18%20.87M | -8.33%156.44M | 1.15%107.74M | 7.92%71.52M | -5.68%27.89M | -33.72%170.65M | -29.99%106.52M | -33.11%66.27M |
| Financial expense | -5.12%26.08M | -4.90%18.02M | -0.90%9.46M | -20.55%40.76M | -26.77%27.49M | -23.79%18.95M | -25.29%9.54M | -40.37%51.3M | -35.62%37.54M | -38.03%24.86M |
| -Interest expense (Financial expense) | -10.55%25.55M | -6.83%17.55M | -20.69%7.65M | -20.06%41.89M | -24.48%28.56M | -25.30%18.83M | -25.04%9.65M | -38.96%52.4M | -35.49%37.82M | -37.07%25.21M |
| -Interest Income (Financial expense) | 94.33%-62.03K | 98.09%-10.65K | 51.97%-107.96K | -7.73%-1.21M | -41.82%-1.09M | -31.13%-556.55K | -14.31%-224.76K | -97.53%-1.12M | -139.80%-771.65K | -72.03%-424.44K |
| Research and development | -39.16%8.56M | -55.09%4.57M | -62.15%1.93M | 47.31%52.51M | -27.50%14.07M | 0.91%10.18M | 4.58%5.1M | -7.73%35.64M | -13.71%19.4M | -38.23%10.09M |
| Credit Impairment Loss | 387.40%6.91M | 49.40%5.77M | 55.08%5.44M | 127.23%3.44M | -50.56%1.42M | 96.10%3.86M | 42.05%3.51M | 67.10%-12.64M | -92.58%2.87M | -95.56%1.97M |
| Asset Impairment Loss | -2,082.60%-1.03M | -357.90%-4.04M | ---- | -109.09%-94.67M | -98.90%52.09K | -71.60%1.57M | -99.97%1.84K | 30.70%-45.28M | 4,762.11%4.72M | 5,581.19%5.52M |
| Other net revenue | 3.21%12.02M | -57.15%5.94M | 125.64%8.23M | -105.77%-36.72M | -42.49%11.65M | -19.60%13.86M | -72.81%3.65M | -107.56%-17.85M | -89.95%20.26M | -91.48%17.24M |
| Fair value change income | ---- | ---- | ---- | 38.54%24.81M | ---- | ---- | ---- | 159.28%17.91M | ---- | ---- |
| Invest income | 41.33%-432.13K | 42.79%-419.01K | -20.42%-27.68K | 200.15%4.1M | 42.33%-736.55K | 39.26%-732.37K | ---22.99K | -101.64%-4.09M | -100.86%-1.28M | -100.81%-1.21M |
| -Including: Investment income associates | 42.27%-425.23K | 42.79%-419.01K | 32.99%-27.68K | 67.84%-1.31M | 42.33%-736.55K | 39.26%-732.37K | ---41.31K | -22.42%-4.09M | 45.12%-1.28M | 48.19%-1.21M |
| Asset deal income | 136.13%135.61K | 121.88%129.63K | 136.12%150.23K | -22.84%7.56M | -14.33%-375.35K | -84.23%-592.33K | -324.24%-415.97K | -85.22%9.8M | 50.51%-328.32K | -779.07%-321.51K |
| Other revenue | -42.94%6.44M | -53.81%4.51M | 363.96%2.66M | 9.63%18.04M | -20.88%11.29M | -13.48%9.76M | -88.90%573.52K | -5.47%16.45M | -4.54%14.27M | 24.60%11.27M |
| Operating profit | -1,223.22%-29.03M | -234.45%-19.62M | -53.01%5.13M | -153.10%-172.91M | -110.38%-2.19M | -45.21%14.59M | -54.66%10.93M | 45.32%-68.32M | -45.78%21.15M | -71.61%26.63M |
| Add:Non operating Income | 315.06%1.45M | -29.28%111.23K | 48.01%104.3K | 1,171.36%10.28M | 10.76%348.97K | 176.74%157.28K | 67.33%70.46K | -90.90%808.96K | -77.77%315.06K | -92.97%56.83K |
| Less:Non operating expense | 1,445.97%79.39M | -81.28%904.08K | -42.32%184.28K | -39.09%11.04M | -50.37%5.14M | -43.77%4.83M | -95.37%319.47K | -36.26%18.12M | -51.25%10.35M | -9.28%8.59M |
| Total profit | -1,432.49%-106.97M | -305.79%-20.41M | -52.67%5.05M | -102.80%-173.67M | -162.79%-6.98M | -45.20%9.92M | -38.07%10.68M | 40.73%-85.63M | -42.09%11.12M | -78.75%18.1M |
| Less:Income tax cost | -99.01%71.03K | -90.82%396.64K | -97.21%53.93K | 241.23%32.84M | -37.00%7.21M | -27.20%4.32M | -61.89%1.93M | -79.17%9.62M | 9,465.01%11.44M | 2,281.48%5.94M |
| Net profit | -654.48%-107.04M | -471.87%-20.81M | -42.82%5M | -116.79%-206.5M | -4,284.27%-14.19M | -53.99%5.59M | -28.14%8.74M | 50.04%-95.25M | -101.70%-323.6K | -85.77%12.16M |
| Net profit from continuing operation | -654.48%-107.04M | -471.87%-20.81M | -42.82%5M | -60.23%-240.82M | -4,284.27%-14.19M | -53.99%5.59M | -28.14%8.74M | 21.18%-150.3M | -101.70%-323.6K | -85.77%12.16M |
| Net income from discontinuing operating | ---- | ---- | ---- | -37.65%34.32M | ---- | ---- | ---- | --55.04M | ---- | ---- |
| Less:Minority Profit | -103.38%-719.27K | -83.78%2.99M | -79.98%1.49M | -68.35%8.64M | -26.96%21.28M | -21.93%18.44M | -15.45%7.46M | 171.97%27.31M | 559.71%29.13M | 1,346.12%23.62M |
| Net profit of parent company owners | -199.79%-106.32M | -85.25%-23.8M | 174.14%3.51M | -75.54%-215.14M | -20.40%-35.47M | -12.07%-12.85M | -61.69%1.28M | 19.75%-122.56M | -300.94%-29.46M | -113.68%-11.46M |
| Earning per share | ||||||||||
| Basic earning per share | -200.00%-0.1209 | -84.93%-0.027 | 166.67%0.004 | -75.52%-0.2445 | -20.30%-0.0403 | -12.31%-0.0146 | -60.53%0.0015 | 19.76%-0.1393 | -300.60%-0.0335 | -113.66%-0.013 |
| Diluted earning per share | -200.00%-0.1209 | -84.93%-0.027 | 166.67%0.004 | -75.52%-0.2445 | -20.30%-0.0403 | -12.31%-0.0146 | -60.53%0.0015 | 19.76%-0.1393 | -300.60%-0.0335 | -113.66%-0.013 |
| Other composite income | -60.21%147.52K | -104.65%-35.32K | 105.64%33.92K | 295.38%2.2M | 107.67%370.75K | 35.48%758.88K | -601.14K | 94.41%-1.12M | 178.53K | 1,083.78%560.13K |
| Other composite income of parent company owners | -60.21%75.23K | -104.65%-18.02K | 105.64%17.3K | 237.02%862.92K | 107.67%189.08K | 35.48%387.03K | ---306.58K | 96.83%-629.8K | --91.05K | 1,083.78%285.66K |
| Other composite income of minority owners | -60.21%72.28K | -104.65%-17.31K | 105.64%16.62K | 369.66%1.33M | 107.67%181.67K | 35.48%371.85K | ---294.56K | -111.85%-494.88K | --87.48K | 1,083.78%274.46K |
| Total composite income | -673.66%-106.9M | -428.01%-20.84M | -38.18%5.03M | -111.98%-204.3M | -9,424.06%-13.82M | -50.05%6.35M | -33.08%8.14M | 54.27%-96.38M | -100.76%-145.07K | -85.12%12.72M |
| Total composite income of parent company owners | -201.19%-106.25M | -91.15%-23.81M | 262.39%3.52M | -73.94%-214.28M | -20.13%-35.28M | -11.47%-12.46M | -70.88%972.05K | 28.63%-123.19M | -300.32%-29.37M | -113.34%-11.18M |
| Total composite income of minority owners | -103.01%-646.98K | -84.19%2.97M | -78.93%1.51M | -62.79%9.98M | -26.56%21.46M | -21.27%18.81M | -18.79%7.17M | 170.23%26.81M | 561.69%29.22M | 1,342.45%23.9M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Adverse Opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | ZTE Accounting firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
